A nasal spray form of GLP-1 therapy in development
The Hook
“We're building a nasal spray GLP-1. The reason is kind of simple. It's because of my family. I'm prediabetic, my dad's diabetic, and we have Alzheimer's that affects two of my grandparents.”
Problem Agitation
“GLP-1s change what's possible for people like my dad and over 15 million Americans take it monthly. It out earns OpenAI and Anthropic combined.”
Problem Agitation
“But innovating on the molecule and the GLP-1 agonist is not the issue anymore. Delivery is the issue. Today that means a needle, a fridge, and for 50% of patients, it means nausea.”
Product Reveal
“The brain is one of the hardest organs in the body to reach. The blood brain barrier keeps out high molecular weight drugs such as peptides. Our patented nanoparticles can encapsulate and protect the peptide, allowing delivery through the olfactory bulb into the brain. We have shown in preclinical studies that delivery by this method, resulted in higher weight loss in mice compared to the pill and with less vomiting.”
Feature Teaser
“LionBio is developing this nasal spray as a platform technology. Advances in AI driven drug discovery will come up with many promising drugs for neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and addiction.”
Feature Teaser
“So, six months in, we've made a lot of progress already. We've assembled a team with decades of experience and several approved intranasal nanoparticle drugs between them. We finished our first PK study, we signed our manufacturing partner and now we're scaling up.”
Feature Teaser
“I really want LionBio to be a name that people recognize and trust, because most people never get to know the companies that are actually developing the medicine. And that's why I want to bring my background in investing in consumer at a16z into this, and create LionBio into a real consumer brand.”
Call to Action
“It kind of all comes together here. My family, the science, and this place at Columbia. But I think we're just getting started.”
Synthesizable in Remotion · key components of the biotech-founder-pitch template.
Bold sans-serif typography fades and scales subtly over documentary footage, tracking subject walking speed.
Use Remotion interpolate on frame for opacity (0 to 1) and translateY (12px to 0px) combined with spring physics.
Point cloud particles orbit in a spherical shell around a 2D/3D peptide molecule glyph.
Create 300 SVG circle points mapped with polar coordinates (r, theta) modulated by Perlin noise and frame rotation.
Frosted minimalist card with thin outline and vertical title hierarchy sliding horizontally from frame edge.
Animate width using spring({ damping: 14 }) with text staggered by 3 frames using AbsoluteFill and flexbox.Purpose. Ground advanced biotech in relatable human health stakes.
Execution. Warm natural campus walk-and-talk with floating typography.
Purpose. Establish huge market demand and highlight injection/nausea pain points.
Execution. Financial charts and newspaper headlines cutting to laboratory benches.
Purpose. Explain nasal nanoparticle delivery into the brain scientifically.
Execution. Vector brain/nasal anatomical schematic and particle animation.
Purpose. Prove team credibility, manufacturing traction, and consumer-facing ambition.
Execution. Leadership Zoom grid, facility b-roll, and final particle logo lockup.